Differentiation and maturation of human dendritic cells modulated by an exopolysaccharide from an anamorph of Cordyceps sinensis

Biomedicine and Preventive Nutrition

Volumn 1, Issue 2, 2011, Pages 126-131

  Huang, Juan ^a   Song, Dan ^a   Yang, Aizhen ^b   Yin, Haitao ^c   Zhang, Weiyun ^a  

^a NANJING UNIVERSITY   (China)

^b Oncology Center of 81st Hospital   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Exopolysaccharide; Human dendritic cell; Maturation

Indexed keywords

EXOPOLYSACCHARIDE; HLA DR ANTIGEN; INTERLEUKIN 12; MESSENGER RNA; STAT3 PROTEIN; VASCULOTROPIN;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MIXED LYMPHOCYTE REACTION; OPHIOCORDYCEPS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 83655191667     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2011.04.003     Document Type: Article

References (30)

1. Steinman R.M. Some interfaces of dendritic cell biology. APMIS 2003, 111:675-697.
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
3. Lanzavecchia A., Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001, 106:263-266.
4. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151-161.
5. Mellman I., Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106:255-258.
6. Aiba S., Terunuma A., Manome H., Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of costimulatory molecules. Eur J Immunol 1997, 27:3031-3038.
7. Hulette B.A., Ryan C.A., Gerberick G.F. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol Appl Pharmacol 2002, 182:226-233.
8. Hulette B.C., Ryan C.A., Gildea L.A., Gerberick G.F. Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. Toxicol Appl Pharmacol 2005, 209:159-166.
9. De Smedt A.C., Van Den Heucel R.L., Van Tendeloo V.F., Berneman Z.N., Schoeters G.E., Weber E., et al. Phenotype alterations and IL-1beta production in CD34 (+) progenitor- and monocyte- derived dendritic cells after exposure to allergens: a comparative analysis. Arch Dermatol Res 2002, 294:109-116.
10. Boislève F., Kerdine-Romer S., Rougier-Larzat N., Pallardy M. Nickel and DNCB induce CCR7 expression on human dendritic cells through different signalling pathways: role of TNF-alpha and MAPK. J Invest Dermatol 2004, 123:494-502.
11. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
12. Nakano H., Lin K.L., Yanagita M., Charbonneau C., Cook D.N., Kakiuchi T., et al. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat Immunol 2009, 10:394-402.
13. Giermasz A.S., Urban J.A., Nakamura Y., Watchmaker P., Cumberland R.L., Gooding W., et al. Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines. Cancer Immunol Immunother 2009, 58:1329-1336.
14. Melief C.J. Cancer immunotherapy by dendritic cells. Immunity 2008, 29:372-383.
15. Zhang W., Yang J., Chen J., Hou Y., Han X. Immunomodulatory and antitumour effects of an exopolysaccharide fraction from cultivated Cordyceps sinensis (Chinese caterpillar fungus) on tumour-bearing mice. Biotechnol Appl Biochem 2005, 42:9-15.
16. Zhang W., Li J., Qiu S., Chen J., Zheng Y. Effects of the exopolysaccharide fraction (EPSF) from a cultivated Cordyceps sinensis on immunocytes of H22 tumor bearing mice. Fitoterapia 2008, 79:168-173.
17. Sheng L., Chen J., Li J., Zhang W. An exopolysaccharide from cultivated Cordyceps sinensis and its effects on cytokine expressions of immunocytes. Appl Biochem Biotechnol 2011, 163:669-678.
18. Renkl A.C., Wussler J., Ahrens T., Thoma K., Kon S., Uede T., et al. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 2005, 106:946-955.
19. Lagaraine C., Hoarau C., Chabot V., Velge-Roussel F., Lebranchu Y. Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways. Int Immunol 2005, 17:351-363.
20. Ardeshna K.M., Pizzey A.R., Devereux S., Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000, 96:1039-1046.
21. Steinman R.M., Hawiger D., Nussenzweig M.C. Telerogenic dendritic cells. Annu Rev Immunol 2003, 21:685-711.
22. Trinchieri G. The two faces of interleukine 12: a proinflammatory cytokine and a key immunoregulatory molecule produced by antigen-presenting cells. Ciba Found Symp 1995, 195:203-220.
23. Henry C.J., Ornelles D.A., Mitchell L.M., Brzoza-Lewis K.L., Hiltbold E.M. IL-12 produced by dendritic cells augments CD8+T cell activation through the production of the Chemokines CCL1 and CCL17. J Immunol 2008, 181:8576-8584.
24. Del Vecchio M., Bajetta E., Canova S., Lotze M.T., Wesa A., Parmiani G., et al. Interleukin-12: biological properties and clinical application. Clin Cancer Res 2007, 13:4677-4685.
25. Mashreghi M.F., Klemz R., Knosalla I.S., Gerstmayer B., Janssen U., Buelow R., et al. Inhibition of dendritic cell maturation and function is independent of heme oxygenasa 1 but requires the activation of STAT3. J Immunol 2008, 180:7919-7930.
26. Imada K., Leonard W.J. The JAK/STAT pathway. Mol Immunol 2000, 37:1-11.
27. Park S.J., Nakagawa T., Kitamura H., Aatsumi T., Kamon H., Sawa S., et al. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 2004, 173:3844-3854.
28. Nefedova Y., Cheng P., Gilkes D., Blaskovich M., Beg A.A., Sebti S.M., et al. Activation of dendritic cells via inhibition of Jak/STAT3 signaling. J Immunol 2005, 175:4338-4346.
29. Gabrilovich D., Ishida T., Oyama T., Ran S., Kravtsov V., Nadaf S., et al. Vascular endothelial growth factor inhibits the develpoment of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 1998, 92:4150-4166.
30. Zhang W.G., Hauke R. STAT3 phosphorylation induced by vascular endothelial growth factor is associated with regulation of immune responses by dendritic cells. FASEB J 2008, 22(Meeting Abstract Supplement):1076.19.